Yong Le
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Oncology 2
- Peptidase Inhibition and Analysis 1
- Drug Transport and Resistance Mechanisms 1
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Ming Jun Shi (10 shared papers)Minke He (7 shared papers)Qi-jiong Li (5 shared papers)Rong Guo (6 shared papers)Wei Wei (3 shared papers)Ruhai Zou (2 shared papers)Xiaoping Wu (1 shared paper)Ming Dan Zhao (1 shared paper)
- Journals
- Journal of Cancer (2 papers)Oncotarget (1 paper)JAMA Oncology (1 paper)Cancer Medicine (1 paper)Liver International (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Yong Le
11 papers receiving 724 citations
Yong Le's Hit Papers
Peers
Comparison fields: 5 of 49
- Hepatology 485
- Cancer Research 86
- Pathology and Forensic Medicine 86
- Oncology 78
- Pulmonary and Respiratory Medicine 72
Countries citing papers authored by Yong Le
This map shows the geographic impact of Yong Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Le more than expected).
Fields of papers citing papers by Yong Le
This network shows the impact of papers produced by Yong Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Le. The network helps show where Yong Le may publish in the future.
Co-authors
The 25 scholars most cited alongside Yong Le, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion Hit paper breakdown → | 2019 | 425 |
| 2 | 2017 | 118 | |
| 3 | 2018 | 33 | |
| 4 | 2015 | 28 | |
| 5 | 2018 | 28 | |
| 6 | 2019 | 24 | |
| 7 | 2016 | 23 | |
| 8 | 2017 | 17 | |
| 9 | 2018 | 17 | |
| 10 | 2019 | 15 | |
| 11 | 2016 | 1 |
About Yong Le
Yong Le is a scholar working on Hepatology, Oncology, Cancer Research, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 11 papers that have together received 729 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Peptidase Inhibition and Analysis (1 paper), Liver Disease Diagnosis and Treatment (1 paper), Ion Transport and Channel Regulation (1 paper), RNA modifications and cancer (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Drug Transport and Resistance Mechanisms (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Hepatology (485 citations), Cancer Research (86 citations), Pathology and Forensic Medicine (86 citations), Oncology (78 citations) and Pulmonary and Respiratory Medicine (72 citations). Yong Le has collaborated with scholars based in China and United States. Frequent co-authors include Ming Jun Shi, Minke He, Qi-jiong Li, Rong Guo, Wei Wei, Ruhai Zou, Xiaoping Wu, Ming Dan Zhao, Li Xu and Zhongguo Zhou. Their work appears in journals such as Journal of Cancer, Oncotarget, JAMA Oncology, Cancer Medicine and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.